Organoids Derived From Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s Disease
The researchers sampled gut tissue from 53 Crohn’s disease patients during routine colonoscopies at the Inflammatory Bowel Disease Center at
The researchers sampled gut tissue from 53 Crohn’s disease patients during routine colonoscopies at the Inflammatory Bowel Disease Center at
Without treatment, CAEBV patients develop progressive cellular and humoural immune deficiencies complicated by opportunistic infections, haemophagocytic lymphohistiocytosis (HLH), multiple organ
Most people are carriers of EBV: 90% of the adult population are infected with the virus, usually experiencing no symptoms
Increasing evidence indicates a role for EBV in the pathogenesis of multiple sclerosis (MS). EBV-infected autoreactive B cells might accumulate
Because mitochondrial activity can better reflect cell vitality, cell viability was assessed using the ATP assay. A luciferase-based kit (Beyotime
Inflammatory bowel diseases (IBD) are chronic inflammatory conditions that affect the gastrointestinal tract, mainly encompassing Crohn’s disease (CD) and ulcerative
Dynamic interactions between the gastrointestinal epithelium and the mucosal immune system result in intestinal homeostasis and optimal immunosurveillance, but a
Stem cell therapy for inflammatory bowel disease (IBD) presents a revolutionary treatment path for individuals battling the relentless effects of
Stem cell therapy aims to help reduce the underlying inflammation in the mucous lining of your colon when other treatments
Developmentally early cells, including hematopoietic stem progenitor cells (HSPCs), mesenchymal stem cells (MSCs), endothelial progenitor cells (EPCs), and very small
The RHA.org Your Trusted Guide to Regenerative Health
© 2024 All Rights Reserved.